Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, March 31, 2026.
Reported quarterly gross margin; no daily interpolation. Q3 FY2026 (2026-03-31): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
46.60%
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Advanced Biomed Inc. Common Stock
Market Cap
$8.76M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$9.09M
Gross Margin
18.37%
TTM Avg
19.16%
3Y Avg
20.84%
5Y Avg
23.00%
Market Cap
$8.37M
Gross Margin
0.00%
TTM Avg
-261.58%
3Y Avg
-106.09%
5Y Avg
-70.73%
Market Cap
$9.42M
Gross Margin
N/A
TTM Avg
-2933.43%
3Y Avg
-1696.98%
5Y Avg
-1166.77%
Market Cap
$9.63M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$7.75M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.79M
Gross Margin
-3767.20%
TTM Avg
-1960.46%
3Y Avg
-1022.20%
5Y Avg
-664.64%
Market Cap
$10.07M
Gross Margin
92.64%
TTM Avg
97.85%
3Y Avg
48.93%
5Y Avg
32.62%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Advanced Biomed Inc. Common Stock (ADVB) | $8.76M | 0.00% | 0.00% | 0.00% | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $9.09M | 18.37% | 19.16% | 20.84% | 23.00% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.37M | 0.00% | -261.58% | -106.09% | -70.73% |
| HeartSciences Inc. (HSCS)vs › | $9.42M | N/A | -2933.43% | -1696.98% | -1166.77% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.63M | 0.00% | 0.00% | 0.00% | 0.00% |
| GT Biopharma, Inc. (GTBP)vs › | $7.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| Ainos, Inc. (AIMD)vs › | $9.79M | -3767.20% | -1960.46% | -1022.20% | -664.64% |
| SeaStar Medical Holding Corporation (ICU)vs › | $10.07M | 92.64% | 97.85% | 48.93% | 32.62% |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 14.92% | 28.44% | 28.69% | 27.44% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
